Overview
Christine Hodyl is a General Surgeon in Valley Stream, New York. Dr. Hodyl is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Intraductal Papilloma, Giant Mammary Hamartoma, Breast Cancer, Mastectomy, and Lymphadenectomy.
Her clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Breast Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1 S Central Ave, Valley Stream, NY 11580
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Mskcc Surgery Group
Monica Morrow is a General Surgeon in New York, New York. Dr. Morrow is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Mastectomy.
Anees Chagpar is a General Surgeon and a Surgical Oncologist in New Haven, Connecticut. Dr. Chagpar is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, Mastectomy, and Lymphadenectomy.
New York University
Freya Schnabel is a General Surgeon in New York, New York. Dr. Schnabel has been practicing medicine for over 43 years and is rated as an Elite provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Intraductal Papilloma, Giant Mammary Hamartoma, Mastectomy, and Lymphadenectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Hodyl isDistinguished. Learn about Breast Cancer.
- Breast LumpDr. Hodyl isDistinguished. Learn about Breast Lump.
- FibroadenomaDr. Hodyl isDistinguished. Learn about Fibroadenoma.
- Giant Mammary HamartomaDr. Hodyl isDistinguished. Learn about Giant Mammary Hamartoma.
- Inflammatory Breast CancerDr. Hodyl isDistinguished. Learn about Inflammatory Breast Cancer.
- Intraductal PapillomaDr. Hodyl isDistinguished. Learn about Intraductal Papilloma.
- Advanced
- AngiosarcomaDr. Hodyl isAdvanced. Learn about Angiosarcoma.
- Breast InfectionDr. Hodyl isAdvanced. Learn about Breast Infection.
- Fibrocystic Breast DiseaseDr. Hodyl isAdvanced. Learn about Fibrocystic Breast Disease.
- GalactocoeleDr. Hodyl isAdvanced. Learn about Galactocoele.
- PtosisDr. Hodyl isAdvanced. Learn about Ptosis.
- Experienced
- BRCA Positive Breast CancerDr. Hodyl isExperienced. Learn about BRCA Positive Breast Cancer.
- Breast Enlargement In MalesDr. Hodyl isExperienced. Learn about Breast Enlargement In Males.
- CellulitisDr. Hodyl isExperienced. Learn about Cellulitis.
- Epidural LipomatosisDr. Hodyl isExperienced. Learn about Epidural Lipomatosis.
- HER-2 Positive Breast CancerDr. Hodyl isExperienced. Learn about HER-2 Positive Breast Cancer.
- HER2 Negative Breast CancerDr. Hodyl isExperienced. Learn about HER2 Negative Breast Cancer.